Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

K Sideras, PL Schaefer, SH Okuno, JA Sloan… - Mayo Clinic …, 2006 - Elsevier
OBJECTIVE To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …
被引用次数：203 相关文章

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial

K Sideras, PL Schaefer, SH Okuno… - Mayo Clinic …, 2006 - pubmed.ncbi.nlm.nih.gov
Objective To prospectively assess whether low-molecular-weight heparin (LMWH) provides
a survival benefit in patients with advanced cancer. Patients and methods Between …

Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial.

K Sideras, PL Schaefer, SH Okuno, JA Sloan… - Mayo Clinic …, 2006 - europepmc.org
Low-molecular-weight heparin in patients with advanced cancer: a phase 3 clinical trial. -
Abstract - Europe PMC Sign in | Create an account https://orcid.org Europe PMC Menu About …

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

K Sideras, PL Schaefer, SH Okuno, JA Sloan… - Mayo Clinic …, 2006 - infona.pl
To prospectively assess whether low-molecular-weight heparin (LMWH) provides a survival
benefit in patients with advanced cancer. Between December 1998 and June 2001, we …

Low-molecular-weight heparin in patients with advanced cancer: A phase 3 clinical trial

K Sideras, PL Schaefer, SH Okuno… - Mayo Clinic …, 2006 - mayoclinic.elsevierpure.com
OBJECTIVE: To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …
[HTML] jvascsurg.org

[HTML][HTML] Low-molecular-weight heparin in patients with advanced cancer: A phase 3 clinical trial

K Sideras, PL Schaefer, SH Okuno - Journal of Vascular Surgery, 2007 - jvascsurg.org
Conclusion: Low-molecular-weight heparin does not provide survival benefit in patients with
advanced cancer. Summary: It has been suggested that patients with cancer who develop …

Low-molecular-weight heparin in patients with advanced cancer: A phase 3 clinical trial

K Sideras, PL Schaefer, SH Okuno… - Mayo Clinic …, 2006 - experts.illinois.edu
OBJECTIVE: To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …
[PDF] psu.edu

[PDF][PDF] Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

K SIDERAS, PL SCHAEFER, SH OKUNO, JA SLOAN… - Mayo Clin Proc, 2006 - Citeseer
OBJECTIVE: To prospectively assess whether low-molecularweight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

K Sideras, PL Schaefer, SH Okuno… - Mayo Clinic …, 2006 - search.proquest.com
A Phase 3 Clinical Trial Page 1 ORIGINAL ARTICLE Low-Molecular-Weight Heparin in
Patients With Advanced Cancer: A Phase 3 Clinical Trial KOSTANDINOS SIDERAS, MD; …

Low-Molecular-Weight Heparin in Patients With Advanced Cancer: A Phase 3 Clinical Trial

K Sideras, PL Schaefer, SH Okuno… - Mayo Clinic …, 2006 - mayoclinicproceedings.org
OBJECTIVE To prospectively assess whether low-molecular-weight heparin (LMWH)
provides a survival benefit in patients with advanced cancer. PATIENTS AND METHODS …